EUVIMEDOpdag EUVIMED
Video/AudioKohortenstudie

The N-Acetylaspartate to Choline Ratio Differentiates Intracranial Gliomas from Tumefactive Demyelinating Lesions in a Retrospective Cohort Study

Shibo Dong, Hongshan Chu, Xing Xing, Qian Du, Yuan Zhang, Liqiang Sun

Journal of Visualized Experiments · 2026

DOI: 10.3791/71666 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Shibo Dong and 5 co-authors. Institution: Department of Medical Imaging, Hebei General Hospital; beiguoqishi1@163.com. Major MEDLINE topics: Choline, Aspartic Acid, Glioma, Brain Neoplasms.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intracranial gliomas and tumefactive demyelinating lesions (TDLs) often exhibit overlapping features on conventional structural magnetic resonance imaging (MRI), making their differential diagnosis challenging. This retrospective cohort study evaluated the diagnostic performance of quantitative multi-voxel proton magnetic resonance spectroscopy (1H-MRS) for differentiating these lesions. A total of 63 patients with indeterminate intracranial masses, including gliomas, TDLs, and primary central nervous system lymphomas, underwent 1H-MRS. Absolute and relative metabolite ratios were measured within lesional solid cores and contralateral normal-appearing brain tissue. Regions of interest were independently delineated by two blinded neuroradiologists. Although both gliomas and TDLs demonstrated significantly increased choline-to-creatine (Cho/Cr) ratios relative to normal tissue, the Cho/Cr ratio showed limited diagnostic specificity. In contrast, the N-acetylaspartate-to-choline (NAA/Cho) ratio differed significantly between the two groups. The median NAA/Cho ratio was 1.22 (interquartile range [IQR], 0.75-1.60) in TDLs and 0.32 (IQR, 0.20-0.69) in high-grade gliomas. Receiver operating characteristic analysis demonstrated that an NAA/Cho threshold of ≤0.649 yielded a sensitivity of 72.7% (95% confidence interval [CI], 55.8%-84.9%), a specificity of 93.3% (95% CI, 70.2%-98.8%), and an area under the curve (AUC) of 0.848 (95% CI, 0.74-0.96). Inter-reader reproducibility was high, with intraclass correlation coefficients (ICCs) greater than 0.99. These findings suggest that quantitative 1H-MRS, particularly the NAA/Cho ratio, may provide a useful noninvasive metabolic biomarker to support the differentiation of intracranial gliomas from TDLs, although further validation in larger, multicenter cohorts is warranted.

Subjects

MeSH terms (MEDLINE)

CholineAspartic AcidGliomaBrain NeoplasmsDemyelinating DiseasesProton Magnetic Resonance SpectroscopyHumansRetrospective StudiesFemaleDiagnosis, DifferentialMiddle AgedMaleCohort StudiesAdultAged

Substances

CholineAspartic AcidN-acetylaspartate

Authors and institutions

  • Department of Medical Imaging, Hebei General Hospital; beiguoqishi1@163.com.
  • Department of Neurology, Hebei General Hospital.
  • Department of Pathology, Hebei General Hospital.
  • Department of Medical Imaging, Hebei General Hospital.

Cite

APA

Dong, S., Chu, H., Xing, X., Du, Q., Zhang, Y., & Sun, L. (2026). The N-Acetylaspartate to Choline Ratio Differentiates Intracranial Gliomas from Tumefactive Demyelinating Lesions in a Retrospective Cohort Study. Journal of Visualized Experiments. https://doi.org/10.3791/71666

Vancouver

Dong S, Chu H, Xing X, Du Q, Zhang Y, Sun L. The N-Acetylaspartate to Choline Ratio Differentiates Intracranial Gliomas from Tumefactive Demyelinating Lesions in a Retrospective Cohort Study. Journal of Visualized Experiments. 2026. doi:10.3791/71666

BibTeX
@article{Dong2026,
  author = {Dong, Shibo and Chu, Hongshan and Xing, Xing and Du, Qian and Zhang, Yuan and Sun, Liqiang},
  title = {The N-Acetylaspartate to Choline Ratio Differentiates Intracranial Gliomas from Tumefactive Demyelinating Lesions in a Retrospective Cohort Study},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/71666}
}
Start for free →